Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | December 19, 2012

Legislating Women’s Health: A Chance for Radiologists to Step In

States increasingly are mandating that physicians inform patients with dense breasts that mammography may miss some signs of cancer. This trend provides radiologists with a chance to take a more direct role in patient care.

Five states now mandate physicians to inform women with dense breasts that mammography may be of limited value to them. These states — Connecticut, Virginia, Texas, California and New York — require physicians to advise patients that complementary imaging studies, such as ultrasound or MRI, may be needed, if dense fibroglandular tissues are likely to obscure the mammographic signs of cancer. Their laws, however, do not say specifically who should inform patients — the physician who interprets the mammogram or the physician who regularly attends the patient.

This quandary is ready-made for radiologists. Because mammography is a screening exam, patients are seldom referred to radiologists for such studies. Instead the patients themselves typically make the appointments and are then informed by the radiologist of the results.

Only a month ago, radiologists were encouraged by the RSNA president to consider imaging patients on their own and to take a more active role in their care. The recognition of breast density as a complicating factor in women’s health presents the opportunity to act on this advice.

Radiologists can play a pivotal role in the care of women with dense breasts, according to Stamatia Destounis, M.D., an attending radiologist at Elizabeth Wende Breast Clinic in Rochester, New York.

“We want to do this right — we want to educate and inform patients without causing a lot of undue stress and anxiety and fear and we have to try to do (additional testing) that is appropriate in a cost-effective manner,” she told me.

Ultrasound and MRI are the two options. Ultrasound is low cost and widely available. But it is very sensitive and can produce false negatives demonstrated on biopsy. MRI might be indicated, if patients are high-risk due to family history or the presence of the BRC1 or BRC2 gene. This modality is also very sensitive and can lead to biopsies that are negative.

Clearly, to provide optimal care, several challenges must be met. One is to identify patients with dense breasts, identification that is heavily dependent on the skills of the interpreter. The second challenge is to choose the best method for additional testing. The third is correctly interpreting follow-on tests to minimize the number of biopsies.  The fourth is to maintain communication with the patient throughout the diagnostic process — to keep patients informed and not unduly alarmed.

Rhetorically, you might ask, who better to meet these challenges than radiologists? And what better time to act than now, when organized radiology is pushing its members to take a higher profile in the care of patients?

The question without an obvious answer is whether radiologists, who for so long have taken a back seat in the practice of medicine, will act on this opportunity.

Related Content

A 63-year-old multiple #myeloma patient, with skeletal pain. New #FDG avid axillary #lymphadenopathy 62 days (9 weeks) after second #mRNA #vaccination dose. Image used with permission of the Radiological Society of North America (#RSNA)

A 63-year-old multiple myeloma patient, with skeletal pain. New FDG avid axillary lymphadenopathy 62 days (9 weeks) after second mRNA vaccination dose. Image used with permission of the Radiological Society of North America (RSNA)

Feature | Coronavirus (COVID-19) | April 29, 2021 | By Melinda Taschetta-Millane
ACR releases 13 new topics and five revised topics to support referring physicians and other providers in making the most appropriate imaging or treatment decisions
News | Radiology Imaging | April 26, 2021
April 26, 2021 — The American College of Radiology (ACR) released an update to its...
The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

The Imagio Breast Imaging System combines laser light and sound with conventional ultrasound technology to provide fused functional and anatomic images (referred to as optoacoustic/ultrasound or OA/US) in real time, increasing confidence in diagnostic accuracy.

News | Breast Imaging | April 23, 2021
April 23, 2021 — The U.S.
A Norwegian study for the first time reveals benefit of the #PARP inhibitor #Olaparib in patients with early #breastcancer not harboring germline mutations

Getty Images

News | Radiation Therapy | April 22, 2021
April 22, 2021 — Targeted therapy in early stages of breas...
Women at high risk of breast cancer face cost-associated barriers to care even when they have health insurance, a new study has found.

Getty Images

News | Women's Health | April 22, 2021
April 22, 2021 — Women at high risk of breast cancer face cost-associated barriers to care even when they have health
#SiemensHealthineers #Varian #Siemens The transformative combination accelerates the company’s impact on #global #healthcare and establishes a strong partner for #customers and #patients along the entire #cancer care continuum and for many of the most threatening #diseases
News | Radiology Business | April 15, 2021
April 15, 2021 — Siemens Healthineers AG an